Evaluating the Impact of Prior Authorization Requirements for PrEP and PEP in California

Prior authorization requirements have been considered a successful cost containment strategy for health insurance companies. However, previous research indicates that such requirements have negative impacts on medication access and patient adherence. California Senate Bill 159 is a current proposal to prohibit health plans and insurers from requiring prior authorization and step therapy requirements for Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP.) This policy brief reveals the perspectives of clinical providers of PrEP/PEP and PrEP/PEP navigators in California on prior authorization requirements to prescribe PrEP and PEP.


Send this to a friend